Kommentar zu Kontinuierliche Glukosemessung: am besten dauerhaft beibehalten!

• Literatur

• 1 Lind M, Polonsky W, Hirsch IB. et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA 2017; 317: 379-387
• 2 Beck RW, Riddlesworth TD, Ruedy K. DIAMOND Study Group. et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med 2017; 167: 365-374
• 3 Martens T, Beck RW, Bailey R. MOBILE Study Group. et al. Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. JAMA 2021; 325: 2262-2272
• 4 Beck RW, Bergenstal RM, Riddlesworth TD. et al. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care 2019; 42: 400-405
• 5 Lu J, Wang C, Shen Y. et al. Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: a prospective cohort study. Diabetes Care 2021; 44: 549-555
• 6 Battelino T, Conget I, Olsen B. SWITCH Study Group. et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 2012; 55: 3155-3162
• 7 Lind M, Polonsky W, Hirsch IB. et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA 2017; 317: 379-387